Clinical Trials Directory

Trials / Completed

CompletedNCT04105075

COPD in Obese Patients

Features of Chronic Obstructive Pulmonary Disease Clinical Course in Obese Patients

Status
Completed
Phase
Study type
Observational
Enrollment
176 (actual)
Sponsor
Voronezh N.N. Burdenko State Medical Academy · Academic / Other
Sex
All
Age
30 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The study included 176 patients with COPD. The first group included 88 normal weight patients with COPD: 71 men and 17 women, mean age 62.40 ± 8.83 years. The second group included 88 patients with COPD and obesity: 64 men and 24 women, mean age 62.94 ± 5.96 years. We assessed the frequency of COPD exacerbations in last 12 months, the severity of symptoms such as dyspnea, sputum production, fatigue. Spirometry, six-minute walk test and analysis of body tissue type composition were performed. BODE index was calculated. Levels of leptin, adiponectin, interleukins-4,6,8,10, interferon-γ, c-reactive protein (CRP), tumor necrosis factor receptor 1 (TNF-R1), tumor necrosis factor receptor 2 (TNF-R2), tumor necrosis factor alpha (TNF-α) were measured in blood serum.

Conditions

Timeline

Start date
2018-09-09
Primary completion
2019-09-10
Completion
2019-09-20
First posted
2019-09-26
Last updated
2019-10-03

Locations

1 site across 1 country: Russia

Source: ClinicalTrials.gov record NCT04105075. Inclusion in this directory is not an endorsement.

COPD in Obese Patients (NCT04105075) · Clinical Trials Directory